Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition

Frontiers in Oncology

Volumn 4, Issue NOV, 2014, Pages

  Lindsey, Stephan ^a   Langhans, Sigrid A ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Epithelial mesenchymal transition; Invasion; Microenvironment; Motility; Transforming growth factor beta

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; HYPOXIA INDUCIBLE FACTOR; MICRORNA; NOTCH RECEPTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; WNT PROTEIN;

APOPTOSIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CIRCULATING TUMOR CELL; E BOX ELEMENT; EPIGENETIC MODIFICATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC DISORDER; GROWTH DISORDER; HUMAN; INFLAMMATION; NONHUMAN; ONCOLOGICAL PARAMETERS; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84915809785     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00358     Document Type: Review

References (115)

1. Mjaatvedt CH, Markwald RR. Induction of an epithelial-mesenchymal transition by an in vivo adheron-like complex. Dev Biol (1989) 136(1):118-28. Epub 1989/11/01. doi: 0012-1606(89)90135-8 [pii]. PubMed PMID: 2509260.
2. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, et al. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis (1994) 12(3):181-94. Epub 1994/05/01. PubMed PMID: 8194193.
3. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol (2003) 15(6):740-6. Epub 2003/12/04. doi: S0955067403001339 [pii]. PubMed PMID: 14644200.
4. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest (2009) 119(6):1438-49. Epub 2009/06/03. doi: 38019 [pii] 10.1172/JCI38019. PubMed PMID: 19487820; PubMed Central PMCID: PMC2689100.
5. Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol (2014) 16(6):488-94. Epub 2014/05/31. doi: ncb2976 [pii] 10.1038/ncb2976. PubMed PMID: 24875735.
6. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 172(7):973-81. Epub 2006/03/29. doi: jcb.200601018 [pii] 10.1083/jcb.200601018. PubMed PMID: 16567498; PubMed Central PMCID: PMC2063755.
7. Chen QK, Lee K, Radisky DC, Nelson CM. Extracellular matrix proteins regulate epithelial mesenchymal transition in mammary epithelial cells. Differentiation (2013) 86(3):126-32. Epub 2013/05/11. doi: S0301-4681(13)00025-X [pii] 10.1016/j.diff.2013.03.003. PubMed PMID: 23660532; PubMed Central PMCID: PMC3762919.
8. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial mesenchymal transition. Bioessays (2001) 23(10):912-23. Epub 2001/10/13. doi: 10.1002/bies.1132 [pii] 10.1002/bies.1132. PubMed PMID: 11598958.
9. Nagathihalli NS, Merchant NB. Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. Front Biosci (Landmark Ed) (2012) 17:2059-69. Epub 2012/06/02. doi: 4037 [pii]. PubMed PMID: 22652764.
10. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 2(2):84-9. Epub 2000/02/03. doi: 10.1038/35000034. PubMed PMID: 10655587.
11. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol (2000) 2(2):76-83. Epub 2000/02/03. doi: 10.1038/35000025. PubMed PMID: 10655586.
12. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell (2006) 10(5):437-49. Epub 2006/11/14. doi: S1535-6108(06)00288-1 [pii] 10.1016/j.ccr.2006.09.013. PubMed PMID: 17097565.
13. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology (2007) 39(3):305-18. Epub 2007/06/15. doi: 779274708 [pii] 10.1080/00313020701329914. PubMed PMID: 17558857.
14. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer (2007) 7(6):415-28. Epub 2007/05/18. doi: nrc2131 [pii] 10.1038/nrc2131. PubMed PMID: 17508028.
15. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci (2003) 116(Pt 3):499-511. Epub 2003/01/01. PubMed PMID: 12508111.
16. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 15(3):178-96. Epub 2014/02/22. doi: nrm3758 [pii] 10.1038/nrm3758. PubMed PMID: 24556840.
17. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem (2001) 276(29):27424-31. Epub 2001/04/20. doi: 10.1074/jbc. M100827200 M100827200 [pii]. PubMed PMID: 11309385.
18. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol (1997) 137(6):1403-19. Epub 1997/06/16. PubMed PMID: 9182671; PubMed Central PMCID: PMC2132541.
19. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 117(7):927-39. Epub 2004/06/24. doi: 10.1016/j.cell.2004.06.006 S0092867404005768 [pii]. PubMed PMID: 15210113.
20. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol (2002) 3(3):155-66. Epub 2002/05/08. doi: 10.1038/nrm757 nrm757 [pii]. PubMed PMID: 11994736.
21. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development (2005) 132(14):3151-61. Epub 2005/06/29. doi: 132/14/3151 [pii] 10.1242/dev.01907. PubMed PMID: 15983400.
22. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al. Snail, Slug, and Smadinteracting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer (2005) 103(8):1631-43. Epub 2005/03/03. doi: 10.1002/cncr.20946. PubMed PMID: 15742334.
23. Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, et al. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res (2006) 12(18):5395-402. Epub 2006/09/27. doi: 12/18/5395 [pii] 10.1158/1078-0432.CCR-06-0478. PubMed PMID: 17000672.
24. Challen GA, Sun D, Mayle A, Jeong M, Luo M, Rodriguez B, et al. Dnmt3a and dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell (2014) 15(3):350-64. Epub 2014/08/19. doi: S1934-5909(14)00266-5 [pii] 10.1016/j.stem.2014.06.018. PubMed PMID: 25130491; PubMed Central PMCID: PMC4163922.
25. Lindsey S, Jiang J, Woulfe D, Papoutsakis ET. Platelets from mice lacking the aryl hydrocarbon receptor exhibit defective collagen-dependent signaling. J Thromb Haemost (2014) 12(3):383-94. Epub 2014/01/15. doi: 10.1111/jth.12490. PubMed PMID: 24410994; PubMed Central PMCID: PMC4008149.
26. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 17(1):9-26. Epub 2009/07/22. doi: S1534-5807(09)00257-3 [pii] 10.1016/j.devcel.2009.06.016. PubMed PMID: 19619488; PubMed Central PMCID: PMC2861485.
27. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature (2005) 434(7035):843-50. Epub 2005/04/15. doi: nature03319 [pii] 10.1038/nature03319. PubMed PMID: 15829953.
28. Wang H, Wang HS, Zhou BH, Li CL, Zhang F, Wang XF, et al. Epithelial-mesenchymal transition (EMT) induced by TNF-alpha requires AKT/GSK-3beta-mediated stabilization of snail in colorectal cancer. PLoS One (2013) 8(2):e56664. Epub 2013/02/23. doi: 10.1371/journal.pone.0056664 PONE-D-12-24230 [pii]. PubMed PMID: 23431386; PubMed Central PMCID: PMC3576347.
29. DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, Naber S, et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res (2009) 69(13):5364-73. Epub 2009/06/25. doi: 0008-5472.CAN-08-4135 [pii] 10.1158/0008-5472.CAN-08-4135. PubMed PMID: 19549913; PubMed Central PMCID: PMC2782448.
30. Friedlander TW, Premasekharan G, Paris PL. Looking back, to the future of circulating tumor cells. Pharmacol Ther (2014) 142(3):271-80. Epub 2013/12/24. doi: S0163-7258(13)00253-2 [pii] 10.1016/j.pharmthera.2013.12.011. PubMed PMID: 24362084.
31. Li YM, Xu SC, Li J, Han KQ, Pi HF, Zheng L, et al. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease. Cell Death Dis (2013) 4:e831. Epub 2013/10/05. doi: cddis2013347 [pii] 10.1038/cddis.2013.347. PubMed PMID: 24091674; PubMed Central PMCID: PMC3824657.
32. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res (2011) 9(8):997-1007. Epub 2011/06/15. doi: 1541-7786.MCR-10-0490 [pii] 10.1158/1541-7786.MCR-10-0490. PubMed PMID: 21665936; PubMed Central PMCID: PMC3157566.
33. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 133(4):704-15. Epub 2008/05/20. doi: S0092-8674(08)00444-3 [pii] 10.1016/j.cell.2008.03.027. PubMed PMID: 18485877; PubMed Central PMCID: PMC2728032.
34. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene (2010) 29(34):4741-51. Epub 2010/06/10. doi: onc2010215 [pii] 10.1038/onc.2010.215. PubMed PMID: 20531305; PubMed Central PMCID: PMC3176718.
35. Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res (2011) 13(3):R59. Epub 2011/06/15. doi: bcr2896 [pii] 10.1186/bcr2896. PubMed PMID: 21663619; PubMed Central PMCID: PMC3218948.
36. Fazilaty H, Gardaneh M, Bahrami T, Salmaninejad A, Behnam B. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway? Tumour Biol (2013) 34(4):2019-30. Epub 2013/05/21. doi: 10.1007/s13277-013-0831-y. PubMed PMID: 23686802.
37. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 9(4):274-84. Epub 2009/03/25. doi: nrc2622 [pii] 10.1038/nrc2622. PubMed PMID: 19308067.
38. Wang H, Xu C, Kong X, Li X, Wang Y, Ding X, et al. Trail resistance induces epithelia mesenchymal transition and enhances invasiveness by suppressing PTEN via miR-221 in breast cancer. PLoS One (2014) 9(6):e99067. Epub 2014/06/07. doi: 10.1371/journal.pone.0099067 PONE-D-13-20961 [pii]. PubMed PMID: 24905916; PubMed Central PMCID: PMC4048247.
39. McDonald B, Spicer J, Giannais B, Fallavollita L, Brodt P, Ferri LE. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer (2009) 125(6):1298-305. Epub 2009/05/12. doi: 10.1002/ijc.24409. PubMed PMID: 19431213.
40. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281-97. Epub 2004/01/28. doi: S0092867404000455 [pii]. PubMed PMID: 14744438.
41. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial mesenchymal transition. Cell Cycle (2008) 7(20):3112-8. Epub 2008/10/18. doi: 6851 [pii]. PubMed PMID: 18927505.
42. Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A, et al. MicroRNA-138 suppresses epithelial mesenchymal transition in squamous cell carcinoma cell lines. Biochem J (2011) 440(1):23-31. Epub 2011/07/21. doi: BJ20111006 [pii] 10.1042/BJ20111006. PubMed PMID: 21770894; PubMed Central PMCID: PMC3331719.
43. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 22(7):894-907. Epub 2008/04/03. doi: 22/7/894 [pii] 10.1101/gad.1640608. PubMed PMID: 18381893; PubMed Central PMCID: PMC2279201.
44. Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, et al. miR-30 inhibits TGF-beta1-induced epithelial-to693 mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun (2012) 417(3):1100-5. Epub 2012/01/10. doi: S0006-291X(11)02330-8 [pii] 10.1016/j.bbrc.2011.12.121. PubMed PMID: 22227196.
45. Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, et al. MicroRNA control of epithelial mesenchymal transition in cancer stem cells. Int J Cancer (2014) 135(5):1019-27. Epub 2014/02/07. doi: 10.1002/ijc.28761. PubMed PMID: 24500893.
46. Weinert T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell (1998) 94(5):555-8. Epub 1998/09/19. doi: S0092-8674(00)81597-4 [pii]. PubMed PMID: 9741620.
47. Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem Suppl (1996) 25:15-22. Epub 1996/01/01. PubMed PMID: 9027593.
48. Roy D, Liehr JG. Estrogen, DNA damage and mutations. Mutat Res (1999) 424(1-2):107-15. Epub 1999/03/05. doi: S0027-5107(99)00012-3 [pii]. PubMed PMID: 10064854.
49. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev (2000) 21(1):40-54. Epub 2000/03/04. doi: 10.1210/edrv.21.1.0386. PubMed PMID: 10696569.
50. McDonald OG, Wu H, Timp W, Doi A, Feinberg AP. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol (2011) 18(8):867-74. Epub 2011/07/05. doi: nsmb.2084 [pii] 10.1038/nsmb.2084. PubMed PMID: 21725293; PubMed Central PMCID: PMC3150339.
51. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet (2009) 10(5):295-304. Epub 2009/03/25. doi: nrg2540 [pii] 10.1038/nrg2540. PubMed PMID: 19308066.
52. von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, Messer M, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology (2009) 137(1):361-71, 71 e1-5. Epub 2009/04/14. doi: S0016-5085(09)00545-9 [pii] 10.1053/j.gastro.2009.04.004. PubMed PMID: 19362090.
53. Ezponda T, Popovic R, Shah MY, Martinez-Garcia E, Zheng Y, Min DJ, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene (2013) 32(23):2882-90. Epub 2012/07/17. doi: onc2012297 [pii] 10.1038/onc.2012.297. PubMed PMID: 22797064; PubMed Central PMCID: PMC3495247.
54. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, CuffJ, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 125(2):315-26. Epub 2006/04/25. doi: S0092-8674(06)00380-1 [pii] 10.1016/j.cell.2006.02.041. PubMed PMID: 16630819.
55. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 448(7153):553-60. Epub 2007/07/03. doi: nature06008 [pii] 10.1038/nature06008. PubMed PMID: 17603471; PubMed Central PMCID: PMC2921165.
56. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell (2007) 1(3):299-312. Epub 2008/03/29. doi: S1934-5909(07)00122-1 [pii] 10.1016/j.stem.2007.08.003. PubMed PMID: 18371364.
57. Zhao XD, Han X, Chew JL, Liu J, Chiu KP, Choo A, et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 1(3):286-98. Epub 2008/03/29. doi: S1934-5909(07)00123-3 [pii] 10.1016/j.stem.2007.08.004. PubMed PMID: 18371363.
58. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell (2009) 4(1):80-93. Epub 2009/01/09. doi: S1934-5909(08)00582-1 [pii] 10.1016/j.stem.2008.11.011. PubMed PMID: 19128795; PubMed Central PMCID: PMC2785912.
59. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 30(1):155-67. Epub 2009/01/16. doi: S1074-7613(08)00555-4 [pii] 10.1016/j.immuni.2008.12.009. PubMed PMID: 19144320; PubMed Central PMCID: PMC2722509.
60. Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, et al. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS One (2009) 4(3):e4687. Epub 2009/03/06. doi: 10.1371/journal.pone.0004687. PubMed PMID: 19262738; PubMed Central PMCID: PMC2650415.
61. Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Oyan AM, et al. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics (2010) 11:669. Epub 2010/11/27. doi: 1471-2164-11-669 [pii] 10.1186/1471-2164-11-669. PubMed PMID: 21108828; PubMed Central PMCID: PMC3012672.
62. Cieslik M, Hoang SA, Baranova N, Chodaparambil S, Kumar M, Allison DF, et al. Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition. Epigenetics Chromatin (2013) 6(1):28. Epub 2013/09/06. doi: 1756-8935-6-28 [pii] 10.1186/1756-8935-6-28. PubMed PMID: 24004852; PubMed Central PMCID: PMC3847279.
63. Liu W, Fan LX, Zhou X, Sweeney WE, Jr., Avner ED, Li X. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells. PLoS One (2012) 7(11):e49418. Epub 2012/11/16. doi: 10.1371/journal.pone.0049418 PONE-D-12-17074 [pii]. PubMed PMID: 23152903; PubMed Central PMCID: PMC3496684.
64. Holbro T, Hynes NE. ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol (2004) 44:195-217. Epub 2004/01/28. doi: 10.1146/annurev.pharmtox.44.101802.121440. PubMed PMID: 14744244.
65. Al Moustafa AE, Achkhar A, Yasmeen A. EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed) (2012) 4:671-84. Epub 2011/12/29. doi: 292 [pii]. PubMed PMID: 22202084.
66. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science (2007) 316(5827):1039-43. Epub 2007/04/28. doi: 1141478 [pii] 10.1126/science.1141478. PubMed PMID: 17463250.
67. Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S, et al. Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene (2014) 33(12):1538-47. Epub 2013/04/23. doi: onc2013102 [pii] 10.1038/onc.2013.102. PubMed PMID: 23604118; PubMed Central PMCID: PMC3883899.
68. Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol (2007) 176(5):695-707. Epub 2007/02/28. doi: jcb.200612129 [pii] 10.1083/jcb.200612129. PubMed PMID: 17325209; PubMed Central PMCID: PMC2064026.
69. Kluppel M, Wrana JL. Turning it up a Notch: cross-talk between TGF beta and Notch signaling. Bioessays (2005) 27(2):115-8. Epub 2005/01/25. doi: 10.1002/bies.20187. PubMed PMID: 15666349.
70. Masuda S, Kumano K, Shimizu K, Imai Y, Kurokawa M, Ogawa S, et al. Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci (2005) 96(5):274-82. Epub 2005/05/21. doi: CAS048 [pii] 10.1111/j.1349-7006.2005.00048.x. PubMed PMID: 15904468.
71. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J (2004) 23(5):1155-65. Epub 2004/02/21. doi: 10.1038/sj.emboj.7600069 7600069 [pii]. PubMed PMID: 14976548; PubMed Central PMCID: PMC380966.
72. Holderfield MT, Hughes CC. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res (2008) 102(6):637-52. Epub 2008/03/29. doi: 102/6/637 [pii] 10.1161/CIRCRESAHA.107.167171. PubMed PMID: 18369162.
73. Bhaskaran N, Souchelnytskyi S. Systemic analysis of TGFbeta proteomics revealed involvement of Plag1/CNK1/RASSF1A/Src network in TGFbeta1-dependent activation of Erk1/2 and cell proliferation. Proteomics (2008) 8(21):4507-20. Epub 2008/09/30. doi: 10.1002/pmic.200700960. PubMed PMID: 18821524.
74. Guo X, Wang XF. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009) 19(1):71-88. Epub 2008/11/13. doi: cr2008302 [pii] 10.1038/cr.2008.302. PubMed PMID: 19002158; PubMed Central PMCID: PMC3606489.
75. Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev (1999) 13(7):804-16. Epub 1999/04/10. PubMed PMID: 10197981; PubMed Central PMCID: PMC316599.
76. Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J, et al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer (2009) 100(1):134-44. Epub 2008/12/18. doi: 6604794 [pii] 10.1038/sj.bjc.6604794. PubMed PMID: 19088723; PubMed Central PMCID: PMC2634691.
77. Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, et al. Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res (2012) 72(5):1290-300. Epub 2012/01/19. doi: 0008-5472.CAN-11-3123 [pii] 10.1158/0008-5472.CAN-11-3123. PubMed PMID: 22253230; PubMed Central PMCID: PMC3350107.
78. Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J Biol Chem (2004) 279(23):24505-13. Epub 2004/03/27. doi: 10.1074/jbc. M400081200 M400081200 [pii]. PubMed PMID: 15044465.
79. Vazquez-Martin A, CufiS, Oliveras-Ferraros C, Torres-Garcia VZ, Corominas-Faja B, Cuyas E, et al. IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations. Sci Rep (2013) 3:2560. Epub 2013/09/03. doi: srep02560 [pii] 10.1038/srep02560. PubMed PMID: 23994953; PubMed Central PMCID: PMC3759044.
80. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144(5):646-74. Epub 2011/03/08. doi: S0092-8674(11)00127-9 [pii] 10.1016/j.cell.2011.02.013. PubMed PMID: 21376230.
81. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol (2006) 1:119-50. Epub 2007/11/28. doi: 10.1146/annurev.pathol.1.110304.100224. PubMed PMID: 18039110.
82. Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen independent human prostate cancer growing in the bone of nude mice. Clin Cancer Res (2003) 9(3):1200-10. Epub 2003/03/13. PubMed PMID: 12631626.
83. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell (1999) 98(2):137-46. Epub 1999/07/31. doi: S0092-8674(00)81009-0 [pii]. PubMed PMID: 10428026; PubMed Central PMCID: PMC2853255.
84. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature (2005) 436(7047):123-7. Epub 2005/07/08. doi: nature03688 [pii] 10.1038/nature03688. PubMed PMID: 16001073; PubMed Central PMCID: PMC2784913.
85. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem (2011) 112(9):2508-17. Epub 2011/05/11. doi: 10.1002/jcb.23175. PubMed PMID: 21557297.
86. Wu Y, Zhou BP. Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 8(20):3267-73. Epub 2009/09/23. doi: 9699 [pii]. PubMed PMID: 19770594; PubMed Central PMCID: PMC3702728.
87. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol (2008) 66(1):1-9. Epub 2007/10/05. doi: S1040-8428(07)00162-X [pii] 10.1016/j.critrevonc.2007.07.004. PubMed PMID: 17913510.
88. Zheng Y, Yang W, Aldape K, He J, Lu Z. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion. J Biol Chem (2013) 288(44):31488-95. Epub 2013/09/21. doi: M113.499020 [pii] 10.1074/jbc. M113.499020. PubMed PMID: 24045955; PubMed Central PMCID: PMC3814745.
89. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 124(2):263-6. Epub 2006/01/28. doi: S0092-8674(06)00055-9 [pii] 10.1016/j.cell.2006.01.007. PubMed PMID: 16439202.
90. Zhang C, Carl TF, Trudeau ED, Simmet T, Klymkowsky MW. An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm. PLoS One (2006) 1:e106. Epub 2007/01/06. doi: 10.1371/journal.pone.0000106. PubMed PMID: 17205110; PubMed Central PMCID: PMC1762408.
91. Massague J. TGFbeta in Cancer. Cell (2008) 134(2):215-30. Epub 2008/07/30. doi: S0092-8674(08)00878-7 [pii] 10.1016/j.cell.2008.07.001. PubMed PMID: 18662538; PubMed Central PMCID: PMC3512574.
92. Kurtzman SH, Anderson KH, Wang Y, Miller LJ, Renna M, Stankus M, et al. Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep (1999) 6(1):65-70. Epub 1998/12/29. PubMed PMID: 9864403.
93. Ben-Baruch A. The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFalpha and Chemokines. Cancer Microenviron (2012) 5(2):151-64. Epub 2011/12/23. doi: 10.1007/s12307-011-0094-3. PubMed PMID: 22190050; PubMed Central PMCID: PMC3399063.
94. Pantschenko AG, Pushkar I, Anderson KH, Wang Y, Miller LJ, Kurtzman SH, et al. The interleukin- 1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol (2003) 23(2):269-84. Epub 2003/07/10. PubMed PMID: 12851675.
95. Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res (2011) 71(13):4707-19. Epub 2011/05/11. doi: 0008-5472.CAN-10-4554 [pii] 10.1158/0008-5472.CAN-10-4554. PubMed PMID: 21555371; PubMed Central PMCID: PMC3129359.
96. Leibovich-Rivkin T, Liubomirski Y, Bernstein B, Meshel T, Ben-Baruch A. Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures. Neoplasia (2013) 15(12):1330-46. Epub 2014/01/10. PubMed PMID: 24403855; PubMed Central PMCID: PMC3884524.
97. Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer (2011) 11(6):393-410. Epub 2011/05/25. doi: nrc3064 [pii] 10.1038/nrc3064. PubMed PMID: 21606941.
98. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol (1992) 3(2):65-71. Epub 1992/04/01. PubMed PMID: 1378311.
99. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 2(1):38-47. Epub 2002/03/21. doi: 10.1038/nrc704. PubMed PMID: 11902584.
100. Zhu QC, Gao RY, Wu W, Qin HL. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev (2013) 14(5):2689-98. Epub 2013/06/28. PubMed PMID: 23803016.
101. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist (2004) 9 Suppl 5:10-7. Epub 2004/12/14. doi: 9/suppl_5/10 [pii] 10.1634/theoncologist.9-90005-10. PubMed PMID: 15591418.
102. Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol (2005) 16(4-5):554-63. Epub 2005/09/08. doi: S1084-9521(05)00059-5 [pii] 10.1016/j.semcdb.2005.03.007. PubMed PMID: 16144692.
103. Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, et al. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One (2009) 4(7):e6381. Epub 2009/07/29. doi: 10.1371/journal.pone.0006381. PubMed PMID: 19636430; PubMed Central PMCID: PMC2712688.
104. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 119(6):1429-37. Epub 2009/06/03. doi: 36183 [pii] 10.1172/JCI36183. PubMed PMID: 19487819; PubMed Central PMCID: PMC2689132.
105. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res (2010) 16(24):5928-35. Epub 2010/10/22. doi: 1078-0432.CCR-10-1360 [pii] 10.1158/1078-0432.CCR-10-1360. PubMed PMID: 20962028; PubMed Central PMCID: PMC3005023.
106. Martin A, Cano A. Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol (2010) 12(10):924-5. Epub 2010/10/05. doi: ncb1010-924 [pii] 10.1038/ncb1010-924. PubMed PMID: 20885418.
107. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct regulation of TWIST by HIF- 1alpha promotes metastasis. Nat Cell Biol (2008) 10(3):295-305. Epub 2008/02/26. doi: ncb1691 [pii] 10.1038/ncb1691. PubMed PMID: 18297062.
108. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia induced tumor cell migration and invasion. Proc Natl Acad Sci U S A (2008) 105(17):6392-7. Epub 2008/04/23. doi: 0802047105 [pii] 10.1073/pnas.0802047105. PubMed PMID: 18427106; PubMed Central PMCID: PMC2359811.
109. Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, et al. Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif- 1alpha signaling. Carcinogenesis (2013) 34(5):962-73. Epub 2013/01/30. doi: bgt027 [pii] 10.1093/carcin/bgt027. PubMed PMID: 23358852.
110. Lim JH, Chun YS, Park JW. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res (2008) 68(13):5177-84. Epub 2008/07/03. doi: 68/13/5177 [pii] 10.1158/0008-5472.CAN-07-6234. PubMed PMID: 18593917.
111. Verras M, Papandreou I, Lim AL, Denko NC. Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress. Mol Cell Biol (2008) 28(23):7212-24. Epub 2008/10/01. doi: MCB.00947-08 [pii] 10.1128/MCB.00947-08. PubMed PMID: 18824543; PubMed Central PMCID: PMC2593368.
112. Wang D, Wang Y, Kong T, Fan F, Jiang Y. Hypoxia-induced beta-catenin downregulation involves p53-dependent activation of Siah-1. Cancer Sci (2011) 102(7):1322-8. Epub 2011/04/07. doi: 10.1111/j.1349-7006.2011.01950.x. PubMed PMID: 21466614.
113. Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol (2007) 9(2):210-7. Epub 2007/01/16. doi: ncb1534 [pii] 10.1038/ncb1534. PubMed PMID: 17220880.
114. Shi X, Guo LW, Seedial SM, Si Y, Wang B, Takayama T, et al. TGF-beta/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. Cell Death Dis (2014) 5:e1317. Epub 2014/07/11. doi: cddis2014282 [pii] 10.1038/cddis.2014.282. PubMed PMID: 25010983; PubMed Central PMCID: PMC4123076.
115. Liu L, Gao C, Chen G, Li X, Li J, Wan Q, et al. Notch Signaling Molecules Activate TGF- beta in Rat Mesangial Cells under High Glucose Conditions. J Diabetes Res (2013) 2013:979702. Epub 2013/05/22. doi: 10.1155/2013/979702. PubMed PMID: 23691527; PubMed Central PMCID: PMC3652152. hypoxia916